Therefore, agents that repress ICAM-1 expression in breast cancer cells and subsequently blocks the interaction between cancer and endothelial cells might be an important therapeutic target for repressing the metastatic potential of cancer cells. This evidence concerns the gene ICAM1 and breast carcinoma.